Dicerna pharmaceuticals, inc. (DRNA)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
CASH FLOWS FROM OPERATING ACTIVITIES:
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-22,492

-39,670

-30,790

-23,845

-26,154

-18,611

-19,020

-35,643

-15,579

-15,741

-15,033

-15,225

-14,201

-14,022

-14,176

-15,622

-15,693

-15,635

-16,944

-16,176

-14,084

-14,590

-11,190

-11,355

-10,804

-6,719

-4,194

-3,786

-3,819

Adjustments to reconcile net loss to net cash provided by operating activities:
Stock-based compensation expense

8,527

5,107

4,995

3,893

4,827

2,215

2,148

1,778

1,747

1,767

1,970

2,026

2,007

2,098

2,272

2,410

2,385

2,358

2,393

2,661

2,320

2,013

1,607

2,405

2,212

342

93

27

33

Depreciation and amortization expense

535

378

337

297

242

220

187

198

195

229

208

205

158

173

213

207

207

198

190

175

164

429

158

91

170

181

288

135

136

Loss on disposal of property and equipment

-

-

-

-

-

-

-

-

-

-

0

0

-51

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of premium on investments

191

380

882

1,072

1,225

736

195

105

90

275

-71

-42

7

-138

1

28

36

34

47

32

21

-

-

-

-

-

-

61

49

Non-cash lease expense

1,803

1,360

471

471

445

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6

Increase in fair value of preferred stock warrant

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

2,559

-345

342

-118

-5

Changes in operating assets and liabilities:
Litigation settlement payable

0

0

0

0

-10,500

-2,297

3,893

8,904

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

156,074

217,353

-4,761

-5,682

4,893

178,551

-1,545

-1,545

-1,545

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and license receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-5,018

Prepaid expenses and other assets

6,802

-2,455

4,244

2,953

-886

-220

-625

1,317

-1,004

-504

950

258

755

114

353

314

-367

-282

-105

581

-17

579

-352

309

635

40

-39

-56

-2

Accounts payable

957

1,876

-1,604

731

1,064

172

-226

1,732

-2,895

-488

1,713

-407

-192

661

403

807

-227

1,251

-267

-125

525

22

153

349

-621

-243

871

45

-557

Contract receivables

-185,354

197,354

3,000

0

-100,000

100,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses and other liabilities

-488

647

7,974

2,601

-1,735

1,929

1,472

-139

712

173

-312

-188

-84

-434

73

1,161

-1,342

-1,758

1,222

2,411

365

460

654

860

682

768

213

-165

200

Lease liability

2,131

7,518

496

496

456

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other

-62

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-35

-25

-

8

9

9

11

16

17

16

Net cash provided by operating activities

321,084

-14,924

-32,000

-26,055

72,287

61,640

-11,069

-15,822

-16,451

-5,954

-12,475

-13,889

-13,009

-11,590

-11,615

-11,275

-14,267

-13,270

-13,314

-11,568

-10,647

-12,325

-8,168

-7,825

-6,446

-5,629

-2,594

-3,768

1,047

CASH FLOWS FROM INVESTING ACTIVITIES:
Maturities of held-to-maturity investments

84,000

112,000

78,000

140,000

88,000

31,000

15,000

15,000

20,000

25,000

20,000

10,000

15,000

15,000

15,000

13,000

5,500

16,500

41,000

5,000

7,500

-

-

-

-

-

-

-

-

Purchases of held-to-maturity investments

349,155

42,201

97,633

172,835

49,451

144,673

108,909

0

29,790

-

-

-

-

15,015

0

0

20,016

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of property and equipment

1,380

1,035

1,458

1,576

2,280

114

72

39

134

0

75

0

58

74

96

152

127

139

356

205

434

1,003

202

652

156

-

-

-

-

Other

-15

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from public offering of common stock, net of transaction costs (Note 8)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

94,148

-

-

-

-

Net cash (used in) provided by investing activities

-266,520

68,764

-21,091

-34,411

36,269

-113,787

-93,981

14,961

-9,924

134

4,980

-39,908

14,942

-89

14,904

12,848

-14,643

16,362

40,644

-31,071

7,066

6,481

-37,766

-44,320

-156

-

-

-

-

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock, net of placement agent commissions

39,192

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments of common stock offering costs

0

0

0

0

50

703

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercises of stock options and issuances under Employee Stock Purchase Plan

588

6,268

0

646

196

278

924

241

667

75

128

1

86

0

68

0

493

24

151

28

224

-

-

-

-

-

-

-

-

Other

-12

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercised stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7

755

-

0

0

11

Settlement of restricted stock for tax withholding

-

-

-

-

-

0

0

0

35

0

0

0

11

0

0

0

27

1

0

0

75

-

-

-

-

-

-

-

-

Repayments of long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

3,922

1,104

1,076

1,046

1,020

998

Net cash provided by financing activities

39,768

52,096

0

646

146

59,987

109,023

241

632

43,277

-322

69,701

75

0

68

0

466

23

-295

45,912

149

96

17

-3,915

93,799

-2,267

55,654

1,882

-987

NET INCREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH EQUIVALENTS

94,332

105,940

-53,095

-59,820

108,702

7,840

3,973

-620

-25,743

37,457

-7,817

15,904

2,008

-11,679

3,357

1,573

-28,444

3,115

27,035

3,273

-3,432

-5,748

-45,917

-56,060

87,197

-8,117

52,871

-1,889

60

NONCASH OPERATING ACTIVITIES
Right-of-use assets acquired through operating leases

1,101

25,058

0

0

667

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Redeemable convertible preferred stock issuance costs included in accounts payable

-

-

-

-

-

-

-

-

-

-

-

-170

620

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

NONCASH INVESTING ACTIVITIES
Property and equipment purchases included in accounts payable and accrued expenses

259

727

-527

-336

863

1,604

38

6

0

-

-

-

12

1

23

-15

44

-

-

-

-

-

-

-

-

-

-

-

-

NONCASH FINANCING ACTIVITIES
Common stock offering costs included in accounts payable or accrued expenses

104

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Right-of-use assets acquired through financing leases

48

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant conversion to common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

3,088

-

-

-

-